The alphanumeric identifier "Os08g0491700" follows the nomenclature for rice (Oryza sativa) gene identifiers, where:
Os: Oryza sativa (species code for rice).
08: Chromosome 8.
g: Gene.
0491700: Specific locus identifier.
If such an antibody exists, its applications might include:
| Application | Description |
|---|---|
| Plant Biology Research | Studying gene expression, protein localization, or stress responses in rice. |
| Agricultural Biotechnology | Engineering disease-resistant rice varieties or analyzing metabolic pathways. |
| Phytopathology | Detecting pathogens that interact with rice proteins. |
Given the lack of available data, the following actions are recommended:
Confirm the correct gene identifier using resources like:
Rice Genome Annotation Project (RGAP).
National Center for Biotechnology Information (NCBI) Gene database.
Search repositories that catalog research antibodies, such as:
| Database | Focus |
|---|---|
| CiteAb | Antibody search engine with supplier links. |
| Antibody Registry | Global antibody identifiers and metadata. |
| Thermo Fisher Antibodies | Commercial antibodies for research. |
Use platforms like PubMed or Google Scholar with keywords:
"Os08g0491700 + antibody,"
"Oryza sativa chromosome 8 antibody,"
"Rice gene 0491700 protein antibody."
If developing this antibody, the process would involve:
Os08g0491700 is a gene located on chromosome 8 of rice (Oryza sativa) that encodes a protein with significant research interest in plant molecular biology. Antibodies against this protein enable researchers to investigate its expression patterns, subcellular localization, protein-protein interactions, and functional roles in plant development and stress responses. The development of specific antibodies is crucial for advancing our understanding of gene function through protein-level analysis, complementing genomic and transcriptomic approaches.
Researchers typically have access to both polyclonal and monoclonal antibodies for Os08g0491700 protein detection. Polyclonal antibodies offer broader epitope recognition but may have higher background, while monoclonal antibodies provide high specificity for particular epitopes. For Os08g0491700, researchers should consider the protein's structural characteristics when selecting antibody type. Monoclonal antibodies with high neutralizing activity have been shown to recognize conserved epitopes with high affinity, as demonstrated in similar research contexts . The choice depends on experimental goals - polyclonals for initial detection and monoclonals for specific domain targeting.
For optimal Western blot results with Os08g0491700 antibodies, researchers should:
Extract proteins using a buffer containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 1% Triton X-100, 0.1% SDS, 1mM EDTA, and protease inhibitor cocktail.
Determine protein concentration using Bradford or BCA assay to ensure equal loading.
Denature samples at 95°C for 5 minutes in Laemmli buffer with 2-mercaptoethanol.
Load 20-30μg of total protein per well on 10-12% SDS-PAGE gels.
Transfer to PVDF membranes at 100V for 60-90 minutes.
Block with 5% non-fat dry milk in TBST for 1 hour at room temperature.
Incubate with primary Os08g0491700 antibody at 1:1000 dilution overnight at 4°C.
Wash 3 times with TBST and incubate with HRP-conjugated secondary antibody.
Develop using ECL substrate and appropriate imaging system.
This protocol ensures consistent detection while minimizing background, similar to methodologies used in other antibody characterization studies .
Comprehensive validation of Os08g0491700 antibodies requires multiple approaches:
Knockout/knockdown controls: Compare antibody signal between wild-type and Os08g0491700 CRISPR-Cas9 knockout or RNAi knockdown plants.
Peptide competition assay: Pre-incubate antibody with excess synthetic peptide used for immunization to confirm signal elimination.
Heterologous expression: Express recombinant Os08g0491700 protein with epitope tags in bacterial or insect systems and confirm co-detection with tag-specific antibodies.
Cross-reactivity assessment: Test reactivity against related rice proteins and homologs from other species.
Mass spectrometry validation: Perform immunoprecipitation followed by MS to confirm the identity of captured proteins.
Antibody specificity assessment should include testing against multiple variants of the target protein to ensure recognition of conserved epitopes, similar to approaches used for characterizing monoclonal antibodies against variable targets .
For successful immunoprecipitation of Os08g0491700 protein complexes, researchers should optimize:
Lysis buffer composition: Use 50mM HEPES (pH 7.5), 150mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 1mM EDTA, 1mM PMSF, and protease inhibitor cocktail.
Protein-antibody binding: Incubate 500-1000μg of total protein with 2-5μg of Os08g0491700 antibody overnight at 4°C with gentle rotation.
Bead selection: Protein A/G magnetic beads often yield better results than agarose beads for plant samples.
Binding and washing conditions: After antibody binding, add beads for 2-3 hours at 4°C, then wash 4-5 times with decreasing salt concentrations.
Elution methods: Compare acidic elution (100mM glycine, pH 2.5), high-salt elution, and direct boiling in sample buffer.
Cross-linking consideration: For weak or transient interactions, consider using DSP or formaldehyde crosslinking.
The affinity between antibody and target protein is critical, with optimal antibodies displaying KD values in the low nanomolar range (1-10nM), as observed in related antibody characterization studies .
For ChIP applications with Os08g0491700 antibodies, researchers should:
Cross-link protein-DNA complexes: Treat rice seedlings or tissues with 1% formaldehyde for 10 minutes, quench with 0.125M glycine.
Chromatin preparation: Isolate nuclei, sonicate to achieve DNA fragments of 200-500bp.
Immunoprecipitation: Pre-clear chromatin with protein A/G beads, then incubate with Os08g0491700 antibody (2-5μg) overnight at 4°C.
Washing and elution: Perform sequential washes with low-salt, high-salt, LiCl, and TE buffers; elute with 1% SDS, 0.1M NaHCO3.
Reverse cross-linking: Incubate at 65°C overnight with NaCl addition.
DNA purification and analysis: Extract DNA, perform qPCR or next-generation sequencing.
Validation should include IgG negative controls and positive controls with known DNA-binding proteins. The specificity of ChIP signals can be validated using CRISPR-Cas9 knockout lines lacking Os08g0491700, similar to validation approaches used in antibody characterization research .
For reliable immunolocalization with Os08g0491700 antibodies, implement these essential controls:
Negative controls:
Primary antibody omission
Non-immune serum/IgG substitution
Os08g0491700 knockout/knockdown tissue samples
Peptide competition control
Positive controls:
Tissues with known high Os08g0491700 expression
Co-localization with organelle markers if subcellular localization is known
Transgenic plants expressing tagged Os08g0491700
Technical controls:
Autofluorescence assessment
Non-specific secondary antibody binding check
Multiple fixation methods comparison (4% paraformaldehyde vs. methanol)
When evaluating antibody performance, researchers should test recognition across multiple tissue types and developmental stages, with appropriate quantification of signal specificity. Similar control approaches have been validated in antibody characterization studies where researchers assessed binding specificity across multiple variants .
Optimization for immunohistochemistry requires tissue-specific adjustments:
| Parameter | Leaf Tissue | Root Tissue | Reproductive Tissues |
|---|---|---|---|
| Fixation | 4% PFA, 2 hours | 4% PFA, 4 hours | 4% PFA, overnight |
| Embedding medium | Paraffin | Paraffin or resin | Paraffin |
| Section thickness | 5-8 μm | 8-10 μm | 8-12 μm |
| Antigen retrieval | Citrate buffer, pH 6.0, 20 min | Citrate buffer, pH 6.0, 30 min | EDTA buffer, pH 9.0, 30 min |
| Blocking solution | 5% BSA, 2% normal goat serum | 5% BSA, 5% normal goat serum | 3% BSA, 5% normal goat serum |
| Primary antibody dilution | 1:200 | 1:100 | 1:100 |
| Incubation time | Overnight, 4°C | Overnight, 4°C | 48 hours, 4°C |
| Detection system | Fluorescent or HRP | Fluorescent | Fluorescent |
These parameters should be systematically optimized for each tissue type, considering tissue permeability and fixation characteristics. Similar methodological optimization approaches have been used in antibody characterization studies to ensure consistent detection across different sample types .
Key factors affecting ELISA performance with Os08g0491700 antibodies include:
Antibody quality: Affinity (KD preferably <10nM) and specificity directly impact assay performance.
Coating conditions: Optimize antigen concentration (typically 1-10μg/mL), buffer (carbonate buffer pH 9.6), and incubation time (overnight at 4°C).
Blocking efficiency: Test different blockers (BSA, milk, commercial blockers) at varying concentrations (2-5%).
Sample preparation: Standardize extraction methods to ensure consistent protein yield and quality.
Antibody concentration: Establish optimal primary and secondary antibody dilutions through titration (typically 1:500-1:5000).
Incubation parameters: Optimize temperature (4°C, room temperature, 37°C) and duration (1-24 hours).
Signal development: Compare different substrates (TMB, ABTS) and determine optimal development time.
Plate selection: Test different ELISA plate types for optimal protein binding.
Sensitivity can be maximized through sandwich ELISA formats using capture and detection antibodies targeting different epitopes of Os08g0491700. Similar optimization approaches have been documented in antibody characterization studies showing that binding affinities in the nanomolar range correlate with optimal assay performance .
To mitigate non-specific binding with Os08g0491700 antibodies:
Increase blocking stringency: Use 5% BSA or commercial blockers with 0.1-0.3% Tween-20.
Optimize antibody dilution: Test serial dilutions (1:100 to 1:5000) to find optimal signal-to-noise ratio.
Add carrier proteins: Include 0.1-0.5% non-fat dry milk or 1% fish gelatin in antibody diluent.
Increase wash stringency: Use PBS-T with 0.1-0.5% Tween-20 and increase wash cycles to 5-6 times.
Pre-absorb antibody: Incubate with leaf extract from Os08g0491700 knockout plants to remove cross-reactive antibodies.
Adjust salt concentration: Increase NaCl to 250-500mM in wash and antibody diluent buffers.
Consider detergent optimization: Test different detergents (Triton X-100, NP-40) at 0.1-0.5%.
Sequential epitope exposure: For IHC, test different antigen retrieval methods sequentially.
The key metric for successful optimization is a clear distinction between positive signal in wild-type samples and background in negative controls. Studies on monoclonal antibody characterization emphasize the importance of thorough validation to distinguish specific from non-specific binding .
For accurate quantification of Os08g0491700 protein levels:
Western blot densitometry:
Use housekeeping proteins (actin, tubulin, GAPDH) as loading controls
Implement three technical and biological replicates minimum
Establish linear dynamic range of detection
Normalize to total protein using stain-free gels or Ponceau staining
ELISA quantification:
Generate standard curves using recombinant Os08g0491700 protein
Ensure readings fall within the linear range of the standard curve
Use four-parameter logistic regression for standard curve fitting
Calculate inter- and intra-assay coefficients of variation (CV<15%)
Proteomics approaches:
Implement stable isotope labeling for relative quantification
Use multiple reaction monitoring (MRM) for targeted quantification
Identify at least 3 unique peptides for protein identification
Apply appropriate statistical tests (ANOVA with post-hoc tests)
For all approaches, researchers should report confidence intervals and perform power analysis to determine appropriate sample sizes. Quantitative analyses should follow similar rigor to those employed in antibody characterization studies where binding affinities are precisely determined using methods like biolayer interferometry .
When facing contradictory results between detection methods:
Systematic comparison analysis:
Document differences in epitope recognition between antibodies
Evaluate buffer composition effects on epitope accessibility
Compare fixation/extraction methods and their impact on protein conformation
Assess detection limits of each method using recombinant protein controls
Technical validation:
Confirm antibody specificity via knockout/knockdown controls in each assay format
Validate with orthogonal methods (mass spectrometry, RNA expression)
Test multiple antibodies targeting different epitopes
Implement peptide competition controls in each assay format
Biological considerations:
Evaluate post-translational modifications affecting epitope recognition
Consider protein-protein interactions masking epitopes
Assess tissue-specific or subcellular localization differences
Examine developmental stage-specific expression patterns
When reporting conflicting results, researchers should provide a comprehensive comparison table outlining methodological differences and control experiments. Similar approaches for reconciling contradictory results have been described in antibody characterization studies where multiple binding assays were compared .
For investigating protein-protein interactions:
Co-immunoprecipitation (Co-IP):
Optimize lysis conditions to preserve interactions (milder detergents like 0.5% NP-40)
Consider crosslinking for transient interactions (1% formaldehyde, 10 minutes)
Validate interactions bidirectionally using antibodies against both proteins
Confirm specificity with knockout/knockdown controls
Analyze by Western blot or mass spectrometry
Proximity ligation assay (PLA):
Optimize fixation to maintain tissue architecture and protein interactions
Use pairs of antibodies raised in different species
Implement distance controls (proteins known to co-localize or not)
Quantify PLA signals using appropriate imaging software
Validate with FRET or BiFC in transgenic plants
Antibody-based protein arrays:
Immobilize Os08g0491700 antibody on array surfaces
Incubate with plant extracts under varying conditions
Detect captured interactors with specific antibodies or mass spectrometry
Validate key interactions with targeted Co-IP experiments
Researchers should implement appropriate statistical analyses and controls to distinguish specific from non-specific interactions. Similar methodological approaches have been employed in antibody characterization studies where competitive binding assays helped elucidate interaction mechanisms .
For single-cell immunohistochemistry:
Tissue preparation optimization:
Test multiple fixatives (4% PFA, acetone, methanol) for epitope preservation
Optimize cell wall digestion (1-2% cellulase, 0.1-0.5% macerozyme)
Consider mechanical isolation methods for certain cell types
Use vibratome sectioning (100-150μm) for maintaining 3D architecture
Signal amplification strategies:
Implement tyramide signal amplification for low-abundance proteins
Use quantum dots or other high-brightness fluorophores
Consider multiplex detection with spectrally distinct fluorophores
Optimize antibody concentration for single-cell detection (typically 2-5× higher)
Imaging and analysis:
Use confocal microscopy with appropriate resolution for subcellular localization
Implement deconvolution algorithms to enhance signal clarity
Establish quantitative image analysis workflows
Consider super-resolution techniques for co-localization studies
Validation approaches:
Use fluorescent protein fusions as controls in transgenic plants
Implement RNA in situ hybridization as complementary approach
Validate with multiple antibodies targeting different epitopes
Include cell-type-specific markers for accurate identification
Single-cell approaches should include rigorous controls and quantification methods to account for cell-to-cell variability. Similar attention to microscopy optimization has been described in antibody characterization studies where spatial binding patterns were analyzed .
Epitope mapping provides several advantages for research applications:
Mapping approaches:
Peptide array analysis: Synthesize overlapping peptides (15-20 amino acids) covering Os08g0491700 sequence
Mutagenesis: Create point mutations in recombinant Os08g0491700 protein
Hydrogen-deuterium exchange mass spectrometry for conformational epitopes
X-ray crystallography or cryo-EM for detailed structural characterization
Application benefits:
Predict cross-reactivity with homologous proteins
Design blocking peptides for specificity validation
Select antibodies recognizing functional domains
Understand sensitivity to post-translational modifications
Interpretation framework:
Correlate epitope location with protein structure and function
Compare epitope conservation across rice varieties and related species
Assess epitope accessibility in native vs. denatured conditions
Evaluate epitope overlap with protein-protein interaction sites
| Epitope Region | Recommended Applications | Limitations | Conservation Across Species |
|---|---|---|---|
| N-terminal (aa 1-100) | Western blot, IP | Limited IHC performance | High in Oryza genus |
| Central domain (aa 101-250) | ELISA, Western blot | Requires denaturation | Moderate across Poaceae |
| C-terminal (aa 251-350) | IHC, IP, ChIP | Sensitivity to proteolysis | Variable |
| Conformational epitopes | Native IP, Flow cytometry | Lost in denaturation | Low conservation |
Detailed epitope characterization is essential for interpreting results across different experimental contexts. This approach parallels methods used in antibody characterization studies where amino acid contacts between antibodies and their targets were precisely mapped .